08/16/2026
Ajay Goel, Ph.D., professor and chair of the Department of Molecular Diagnostics and Experimental Therapeutics at City of Hope, led an international study published in The Lancet Gastroenterology & Hepatology that may transform how colorectal cancer is screened.
The study, involving more than 1,600 participants, developed a blood-based test that detected 91% of colorectal cancers and 81% of advanced adenomas, the precancerous lesions that have historically been one of the most difficult targets for blood-based tests to detect.
Dr. Goel shares more on the study and what it could mean for patients in a new City of Hope Research News feature story.
đź”— https://bit.ly/4x2J4MK